The Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026 Date of Board Meeting to be held on 11/08/2026 has been revised to 12/08/2026

06™ August, 2026 The General Manager-Listing Corporate Relationship Department The BSE Limited Ground Floor, PJ Towers, Dalal Street, Mumbai-400001 Security Code: 524632 Dear Sir/Madam, Sub: Intimation of revision in date of Board Meeting pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 29 read with other applicable Regulation of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and in continuation of earlier intimation dated 30® July, 2026, we hereby inform you that the Meeting of the Board of Directors of the Company is scheduled to be held on 12™ August, 2026 instead of 11% August, 2026 at the Registered Office of the Company inter alia to consider and approve the following: - t. Unaudited financial result for the Quarter ended on 30 June, 2026 along with the Auditor's Limited Review Report. 2. Any other business with the permission of Chairman. Please take the same on your record and oblige. Thanking you, Yours faithfully, Director DIN: 10334249 CIN : L24231GJ1993PLC019079 Regd. Office : 3rd Floor, “VEER HOUSE” Opp. WIAA Office, Judges Bunglow Road, Bodakdev, Ahmedabad - 380 054. Factory Add. : 795, Rakanpur, Sola-Santej Road, Ta. Kalol, Dist. Gandhinagar - 382721, Gujarat, India, Ph. : 02764-286317 Email : info@shukrapharmaceuticals.com | Website : www.shukrapharmaceuticals.com